Oglesby A, et al. Patient-reported outcomes after switching to a two-drug regimen of dolutegravir + rilpivirine: Week 100 results from the SWORD-1 and SWORD-2 studies. Abstract P101. HIV/Drug Therapy Glasgow 2018.
Nirmatrelvir nuttig voor niet-opgenomen volwassenen met COVID-19
apr 2022 | Pneumonie, Virale infecties